Skip to main content
Updating results

Food And Drug Administration

  • Updated

A federal advisory panel endorsed a plan to give Pfizer booster shots against COVID-19 to those who are 65 or older or run a risk of severe disease after rejecting a plan to give extra shots to most Americans.

  • Updated

Answer: The Food and Drug Administration said it granted approval to a drug from Biogen based on clinical research results that seemed “reasonably likely” to benefit Alzheimer’s patients.

  • Updated

President Joe Biden predicted a return to some normalcy "by the end of the summer" on Monday, but health experts are increasingly doubtful that the United States will reach herd immunity from Covid-19.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News